➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Mallinckrodt
Moodys
Harvard Business School
Boehringer Ingelheim

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Molidustat


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Molidustat?

Molidustat is an investigational drug.

There have been 9 clinical trials for Molidustat. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2017.

The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Renal Insufficiency, and Anemia. The leading clinical trial sponsors are Bayer and [disabled in preview].

There are seventeen US patents protecting this investigational drug and two hundred and seventy-four international patents.

Recent Clinical Trials for Molidustat
TitleSponsorPhase
Maintenance Treatment of Renal Anemia in Dialysis SubjectsBayerPhase 3
A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis SubjectsBayerPhase 3
A Study of Molidustat for Correction of Renal Anemia in Dialysis SubjectsBayerPhase 3

See all Molidustat clinical trials

Clinical Trial Summary for Molidustat

Top disease conditions for Molidustat
Top clinical trial sponsors for Molidustat

See all Molidustat clinical trials

US Patents for Molidustat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Molidustat   Get Started Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Get Started Free
Molidustat   Get Started Free Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN)   Get Started Free
Molidustat   Get Started Free Method for the preparation of triazole compounds BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)   Get Started Free
Molidustat   Get Started Free Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN)   Get Started Free
Molidustat   Get Started Free Amide-substituted pyridinyltriazole derivatives and uses thereof BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Molidustat

Drugname Country Document Number Estimated Expiration Related US Patent
Molidustat Australia AU2017261372 2036-05-05   Get Started Free
Molidustat Canada CA3023278 2036-05-05   Get Started Free
Molidustat China CN107847398 2036-05-05   Get Started Free
Molidustat European Patent Office EP3452003 2036-05-05   Get Started Free
Molidustat Hong Kong HK1249728 2036-05-05   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Moodys
Baxter
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.